相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The nucleotide prodrug CERC-913 improves mtDNA content in primary hepatocytes from DGUOK-deficient rats
Mark A. Vanden Avond et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Radiosynthesis of [18F]-Labelled Pro-Nucleotides (ProTides)
Alessandra Cavaliere et al.
MOLECULES (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
Mansi Arora et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Aryloxy Triester Phosphoramidates as Phosphoserine Prodrugs: A Proof of Concept Study
Ageo Miccoli et al.
CHEMMEDCHEM (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)
Mairead Geraldine McNamara et al.
FUTURE ONCOLOGY (2020)
A Phosphoramidate Strategy Enables Membrane Permeability of a Non-nucleotide Inhibitor of the Prolyl Isomerase Pin1
Daniel M. C. Schwarz et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Andrea J. Pruijssers et al.
CELL REPORTS (2020)
Synthesis and biological evaluation of aryl phosphoramidate prodrugs of fosfoxacin and its derivatives
Mathilde Munier et al.
BIOORGANIC CHEMISTRY (2019)
Nucleoside Analogues as Antibacterial Agents
Jessica M. Thomson et al.
FRONTIERS IN MICROBIOLOGY (2019)
Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of N-Acetylmannosamine 6-Phosphate
Chiara Morozzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The ProTide Prodrug Technology: Where Next?
Ashwag S. Alanazi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Microwave-assisted organic synthesis of nucleoside ProTide analogues
Cinzia Bordoni et al.
RSC ADVANCES (2019)
Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugs
Ageo Miccoli et al.
MEDCHEMCOMM (2019)
Reactive cyclic intermediates in the ProTide prodrugs activation: trapping the elusive pentavalent phosphorane
Eliska Prochazkova et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
The ProTide Prodrug Technology: From the Concept to the Clinic
Youcef Mehellou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and biological evaluation of 6-substituted-5-fluorouridine ProTides
Magdalena Slusarczyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates
Maxime Bessieres et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and Biological Evaluation of (E)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses
Martin S. Davey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study
Sarah P. Blagden et al.
BRITISH JOURNAL OF CANCER (2018)
Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation
Nicholas A. Lentini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Congenital disorders of glycosylation
Irene J. Chang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors
A. E. J. Yssel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides
Marco Derudas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Kinetin Riboside and Its ProTides Activate the Parkinson's Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
Laura Osgerby et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mechanism-Based Solution to the ProTide Synthesis Problem: Selective Access to Sofosbuvir, Acelarin, and INX-08189
Bryon Simmons et al.
ORGANIC LETTERS (2017)
A multifunctional catalyst that stereoselectively assembles prodrugs
Daniel A. DiRocco et al.
SCIENCE (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Synthetic Approaches for the Preparation of Phosphoramidate Prodrugs of 2′-Deoxypseudoisocytidine
Michaela Serpi et al.
CHEMISTRYOPEN (2017)
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials
Edward J. Gane et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2′-α-chloro-2′-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors
Francois-Rene Alexandre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy
Fabrizio Pertusati et al.
ANTIVIRAL RESEARCH (2017)
Kinase-independent phosphoramidate S1P1 receptor agonist benzyl ether derivatives
Edward James et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
L-Aspartic and L-glutamic acid ester-based ProTides of anticancer nucleosides: Synthesis and antitumoral evaluation
Ling-Jie Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites
Sahar Kandil et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?
Michaela Serpi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Diastereoselective synthesis of P-chirogenic phosphoramidate prodrugs of nucleoside analogues (ProTides) via copper catalysed reaction
F. Pertusati et al.
CHEMICAL COMMUNICATIONS (2015)
Nucleoside analogs and tuberculosis: new weapons against an old enemy
Valentina Ferrari et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Chutes and ladders in hepatitis C nucleoside drug development
Steven J. Coats et al.
ANTIVIRAL RESEARCH (2014)
ProTides of N-(3-(5-(2′-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agents
Christopher McGuigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
Ugo Pradere et al.
CHEMICAL REVIEWS (2014)
PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer
Fabrizio Pertusati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients
Aesop Cho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
Magdalena Slusarczyk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis of an Apionucleoside Family and Discovery of a Prodrug with Anti-HIV Activity
Kiran S. Toti et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Synthesis and biological evaluation of prodrugs of 2-fluoro-2-deoxyribose-1-phosphate and 2,2-difluoro-2-deoxyribose-1-phosphate
Nadege Hamon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis and Biological Evaluation of Purine 2-Fluoro-2-deoxyriboside ProTides as Anti-influenza Virus Agents
Silvia Meneghesso et al.
CHEMMEDCHEM (2013)
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naive patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial
Maribel Rodriguez-Torres et al.
JOURNAL OF HEPATOLOGY (2013)
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Lars Petter Jordheim et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Design, synthesis, and biological evaluation of C1-phosphonamidate analogues of 2-deoxy-D-ribose-l-phosphate
Maurizio Quintiliani et al.
TETRAHEDRON (2013)
Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus
Silvia Meneghesso et al.
ANTIVIRAL RESEARCH (2012)
Novel Phosphoramidate Prodrugs of N-Acetyl-(D)-Glucosamine with Antidegenerative Activity on Bovine and Human Cartilage Explants
Michaela Serpi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
INX-08189, a Phosphoramidate Prodrug of 6-O-Methyl-2′-C-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties
John H. Vernachio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2011)
Phosphoramidate ProTides of the Anticancer Agent FUDR Successfully Deliver the Preformed Bioactive Monophosphate in Cells and Confer Advantage over the Parent Nucleoside
Christopher McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates
Bruce S. Ross et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin
Marco Derudas et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus
Christopher McGuigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
Eisuke Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A New Class of Dual-Targeted Antivirals: Monophosphorylated Acyclovir Prodrug Derivatives Suppress Both Human Immunodeficiency Virus Type 1 and Herpes Simplex Virus Type 2
Christophe Vanpouille et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Diastereoselective Synthesis of Aryloxy Phosphoramidate Prodrugs of 3′-Deoxy-2′,3′-didehydrothymidine Monophosphate
Cristina Arbelo Roman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Phosphoramidate ProTides of 2′-C-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties
Christopher McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of a β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
Michael J. Sofia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The application of the phosphoramidate ProTide approach confers micromolar potency against Hepatitis C virus on inactive agent 4′-azidoinosine: Kinase bypass on a dual base/sugar modified nucleoside
Christopher McGuigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4′-azidocytidine (R1479)
Christopher McGuigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues
Larryn W. Peterson et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
The Application of Phosphoramidate Protide Technology to Acyclovir Confers Anti-HIV Inhibition
Marco Derudas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Successful kinase bypass with new acyclovir phosphoramidate prodrugs
Christopher McGuigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Phosphate prodrugs derived from N-acetylglucosamine have enhanced chondroprotective activity in explant cultures and represent a new lead in antiosteoarthritis drug discovery
Christopher McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Activation of p16 Gene Silenced by DNA Methylation in Cancer Cells by Phosphoramidate Derivatives of 2′-Deoxyzebularine
Christine B. Yoo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
First example of phosphoramidate approach applied to a 4′-substituted purine nucleoside (4′-azidoadenosine):: Conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus
Plinio Perrone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and biological evaluation of phosphate Prodrugs of 4-Phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase
Gian Filippo Ruda et al.
CHEMMEDCHEM (2007)
Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate ProTide' derivatives
Youcef Mehellou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Application of the phosphoramidate ProTide approach to 4′-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside
Plinio Perrone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Acyclic nucleoside phosphonates: Past, present and future - Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: The phosphonate bridge
E. De Clercq
BIOCHEMICAL PHARMACOLOGY (2007)
Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives
Christopher McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Novel potential anticancer naphthyl phosphoramidates of BVdU: Separation of diastereoisomers and assignment of the absolute configuration of the phosphorus center
C Congiatu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Acyclic nucleoside phosphonates: A key class of antiviral drugs
E De Clercq et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency
C McGuigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin
C McGuigan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue
WA Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Phosphoramidate protides of carbocyclic 2 ',3 '-dideoxy-2 ',3 '-didehydro-7-deazaadenosine with potent activity against HIV and HBV
KS Gudmundsson et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections
E De Clercq
CLINICAL MICROBIOLOGY REVIEWS (2003)
Prodrugs of biologically active phosphate esters
C Schultz
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Phosphoramidate protides of 2 ',3 '-dideoxy-3 '-fluoroadenosine and related nucleosides with potent activity against HIV and HBV
KS Gudmundsson et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2003)
Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester Prodrugs of d4T: An in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers
D Siccardi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Mitochondrial DNA depletion and dGK gene mutations
L Salviati et al.
ANNALS OF NEUROLOGY (2002)
Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)2′-deoxyuridine
SA Harris et al.
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY (2001)
Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA
C Ballatore et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
A novel approach to thymidylate synthase as a target for cancer chemotherapy
Q Li et al.
MOLECULAR PHARMACOLOGY (2001)
Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase
DB Lackey et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340
H Chapman et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2001)
Purification of PMPA amidate prodrugs by SMB chromatography and X-ray crystallography of the diastereomerically pure GS-7340
H Chapman et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2001)
Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases
AR Van Rompay et al.
PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
